Compare Crispr Therapeutics AG (CRSP) vs Pinterest Inc (PINS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crispr Therapeutics AG vs Pinterest Inc — how do they compare? Crispr Therapeutics AG trades at $51.6 (market cap $4.97B), while Pinterest Inc trades at $23.7 (market cap $12.66B). The key difference: Pinterest Inc is far larger — about 2.5× Crispr Therapeutics AG's market cap, and Pinterest Inc is trading nearer its 52-week high, Crispr Therapeutics AG nearer its low. Which is the better fit depends on your goals.
| CRSP | PINS | |
|---|---|---|
Market Cap | $4.97B | $12.66B |
Sector | Health | Media |
52-Week High | $76.78 | $39.17 |
52-Week Low | $44.34 | $15.42 |
Enterprise Value | $3.32B | $12.57B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRSP trades at $50.63, down 5.1% over 24 hours, amid a bearish technical signal. The company shows deep losses with a net income margin of -56,853.4% in 2025 and negative cash flow from operations. However, analyst consensus remains optimistic with a $74.50 price target, and recent news highlights FDA approval for Casgevy, expanding its gene therapy market.
The outlook hinges on commercial execution of Casgevy and pipeline progress, offering high growth potential in gene editing. Key risks include sustained cash burn, competitive pressures, and regulatory hurdles. Despite current financial challenges, strong analyst buy ratings suggest confidence in long-term value.
Pinterest (PINS) trades at $22.6, up 0.31% on the day, with a bullish technical outlook and strong analyst consensus. Revenue grew to $4.22B in 2025, with net income of $417M, though Q2 2026 earnings are pending. Recent news highlights AI-driven shopping features and user growth, supporting positive sentiment.
The stock offers upside to the $27.72 consensus target, but high valuation ratios and recent insider selling pose risks. Earnings consistency and competitive pressures in social media remain key watchpoints for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Crispr Therapeutics AG
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →About Pinterest Inc
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →
